22 results
424B5
INM
InMed Pharmaceuticals Inc
3 Jun 22
Prospectus supplement for primary offering
9:45pm
procurement of starting materials sufficient to meet expected customer demand in calendar 1Q2022 for CBDV.
Tetrahydrocannabivarin (THCV)
As part … States Trade Representative identified a number of countries, including India and China, where challenges to the procurement and enforcement of patent
424B3
INM
InMed Pharmaceuticals Inc
25 Apr 22
Prospectus supplement
5:02pm
synthesis to commercial quantities and initiated procurement of starting materials sufficient to meet expected customer demand. Originally scheduled … challenges to the procurement and enforcement of patent rights have been reported. Several countries, including India and China, have been listed
424B3
INM
InMed Pharmaceuticals Inc
7 Apr 22
Prospectus supplement
4:46pm
and initiated procurement of starting materials sufficient to meet expected customer demand in calendar 1Q2022 for CBDV.
Tetrahydrocannabivarin (THCV … the Office of the United States Trade Representative identified a number of countries, including India and China, where challenges to the procurement
S-3
w1aguh 82jn9g66vwo
4 Feb 22
Shelf registration
4:36pm
10-K
5f3y37ts
24 Sep 21
Annual report
7:31am
424B3
kh1s5e6e vk32bymea
22 Jul 21
Prospectus supplement
10:27am
424B3
jc8vrpl
16 Mar 21
Prospectus supplement
12:00am
10-Q
nazsp ody
17 Dec 20
Quarterly report
12:00am
424B4
gcf9wjio0v kd4syc0
13 Nov 20
Prospectus supplement with pricing info
8:52pm
S-1
r3tnyyn6bbgv
19 Jun 20
IPO registration
4:59pm